Abstract | BACKGROUND/OBJECTIVES: METHODS: An anti-cryptococcal antibody EIA was developed to measure CSF antibody response in HIV-infected subjects from Kampala, Uganda and previously healthy, HIV-negative subjects at the National Institutes of Health (NIH) with cryptococcal meningitis. Specimens were tested for cross-reactivity in assays for IgG anti-Histoplasma, anti-Blastomyces and anti-Coccidioides antibodies. RESULTS: Among 61 subjects with cryptococcal meningitis (44 Kampala cohort, 17 NIH cohort), elevated CSF anti-cryptococcal antibody levels existed in 38% (23/61). Of the 23 CSF specimens containing elevated anti-cryptococcal antibodies, falsely positive results were detected in antibody EIAs for histoplasmosis (8/23, 35%), coccidioidomycosis (6/23, 26%) and blastomycosis (1/23, 4%). Overall, 2% (2/81) of control CSF specimens had elevated anti-cryptococcal antibody detected, both from Indiana. CONCLUSIONS:
Cryptococcal meningitis may cause false-positive results in the CSF for antibodies against Histoplasma, Blastomyces and Coccidioides. Fungal antigen testing should be performed to aid in differentiating true- and false-positive antibody results in the CSF.
|
Authors | Nathan C Bahr, Anil A Panackal, Michelle M Durkin, Melinda L Smedema, Wesley Keown, Thomas E Davis, Luke Raymond-Guillen, Yoon-Dong Park, Kieren A Marr, Bettina C Fries, Peter R Williamson, David R Boulware, L Joseph Wheat |
Journal | Mycoses
(Mycoses)
Vol. 62
Issue 3
Pg. 268-273
(Mar 2019)
ISSN: 1439-0507 [Electronic] Germany |
PMID | 30565753
(Publication Type: Journal Article)
|
Copyright | © 2018 Blackwell Verlag GmbH. |
Chemical References |
|
Topics |
- Adult
- Antibodies, Fungal
(analysis)
- Blastomyces
(immunology)
- Cerebrospinal Fluid
(chemistry)
- Coccidioides
(immunology)
- Cross Reactions
- False Positive Reactions
- HIV Infections
(complications)
- Histoplasma
(immunology)
- Humans
- Meningitis, Cryptococcal
(diagnosis)
- Prospective Studies
- Serologic Tests
(methods)
- Uganda
- United States
|